Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions
Clinical trial NCT03234699 · COMPLETED
Trial details
- NCT number
- NCT03234699
- Sponsor
- SK Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2017-07-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.